subscribeSubscribe
price-trendAsk Us
LEO Pharma Announces Positive Phase 3 Head-to-head Data Results from DELTA FORCE Trial Comparing Delgocitinib Cream With Alitretinoin Capsules in Adults With Severe Chronic Hand Eczema (CHE)

LEO Pharma Announces Positive Phase 3 Head-to-head Data Results from DELTA FORCE Trial Comparing Delgocitinib Cream With Alitretinoin Capsules in Adults With Severe Chronic Hand Eczema (CHE)
BUSINESSWIRE
24 Jan 2024
Share Share
Leo Pharma builds its case for JAK inhibitor cream delgocitinib

Leo Pharma builds its case for JAK inhibitor cream delgocitinib
FIERCE PHARMA
24 Jan 2024
Share Share
LEO Pharma Announces Positive Outcome of DELTA 3 Trial of Delgocitinib

LEO Pharma Announces Positive Outcome of DELTA 3 Trial of Delgocitinib
BUSINESSWIRE
30 Oct 2023
Share Share
Leo unveils detailed results on JAK cream win in hand eczema

Leo unveils detailed results on JAK cream win in hand eczema
Fraiser Kansteiner FIERCE PHARMA
13 Oct 2023
Share Share
EMA Accepts LEO Pharma’s MAA for Delgocitinib Cream in CHE

EMA Accepts LEO Pharma’s MAA for Delgocitinib Cream in CHE
BUSINESSWIRE
18 Aug 2023
Share Share
Leo Pharma scores in phase 3 trial for JAK inhibitor cream

Leo Pharma scores in phase 3 trial for JAK inhibitor cream
Zoey Becker FIERCE PHARMA
13 Feb 2023
Share Share
LEO Announces Positive PIII Results From DELTA 2 Trial With Delgocitinib

LEO Announces Positive PIII Results From DELTA 2 Trial With Delgocitinib
BUSINESSWIRE
10 Feb 2023
Share Share
LEO Pharma announces +ve results of Ph2b dose-finding study with delgocitinib

LEO Pharma announces +ve results of Ph2b dose-finding study with delgocitinib
BUSINESSWIRE
30 Oct 2020
Share Share